{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:05Z","timestamp":1792839785706,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ajt.2023.04.024","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:26:41Z","timestamp":1682512001000},"page":"1221-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Transplanting hepatitis B surface antigen\u2013positive livers in the United States: Outcomes and opportunities"],"prefix":"10.1016","volume":"23","author":[{"given":"Anshul","family":"Bhatnagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lymberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjiya","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Naggie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasiha","family":"Kanwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cholankeril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-3447","authenticated-orcid":false,"given":"Tzu-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajt.2023.04.024_bib1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamasurg.2020.2484","article-title":"Trends in outcomes for marginal allografts in liver transplant","volume":"155","author":"Zhang","year":"2020","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.ajt.2023.04.024_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2016.12.004","article-title":"Extended criteria donors in liver transplantation","volume":"21","author":"Vodkin","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.ajt.2023.04.024_bib3","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1600-6143.2007.01758.x","article-title":"Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers","volume":"7","author":"Barshes","year":"2007","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.04.024_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(92)90138-F","article-title":"Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications","volume":"14","author":"O'Grady","year":"1992","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.ajt.2023.04.024_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.ajt.2023.04.024_bib6","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gut.33.10.1390","article-title":"Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation","volume":"33","author":"Lucey","year":"1992","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.ajt.2023.04.024_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/lt.24799","article-title":"The donor risk index: A decade of experience","volume":"23","author":"Flores","year":"2017","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.ajt.2023.04.024_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2014.05.003","article-title":"Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation","volume":"61","author":"Yu","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.ajt.2023.04.024_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/lt.23774","article-title":"Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database","volume":"20","author":"Li","year":"2014","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.ajt.2023.04.024_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cld.2021.06.009","article-title":"Use of hepatitis B virus-positive organs in organ transplantation","volume":"25","author":"Khemichian","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.ajt.2023.04.024_bib11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2023.04.024_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SLA.0000000000005071","article-title":"Expanding the donor pool: first use of hepatitis B virus nat positive solid organ allografts into seronegative recipients","volume":"274","author":"Delman","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ajt.2023.04.024_bib13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.ajt.2023.04.024_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13160","article-title":"Infectious diseases pre-transplant evaluation improves vaccination rates for liver transplant candidates","volume":"21","author":"Pineda","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.ajt.2023.04.024_bib15","first-page":"196","article-title":"Optimizing immunization strategies in adult patients with chronic liver disease and liver transplant recipients","volume":"18","author":"Rolak","year":"2022","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"10.1016\/j.ajt.2023.04.024_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.12659\/AOT.917198","article-title":"Hepatitis B vaccination in patients with liver cirrhosis evaluated for liver transplantation - A simple intervention ensures high adherence","volume":"24","author":"Herta","year":"2019","journal-title":"Ann Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523004288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523004288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:40:45Z","timestamp":1761630045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613523004288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1600613523004288"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2023.04.024","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplanting hepatitis B surface antigen\u2013positive livers in the United States: Outcomes and opportunities","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2023.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}